News

 

Published: Jun 20, 2016

AAGBI guidelines: the use of blood components and their alternatives 2016
Read more on this

 

 

Published: Sep 28, 2015

European Medicines Agency's Committee for Medicinal Products for Human Use recommends marketing authorisation for idarucizumab (Praxbind), a specific reversal agent for dabigatran
Read more on this

 

 

Published: Feb 12, 2015

Anaesthesia Supplement on ‘Transfusion, Thrombosis and Management of Bleeding’
Read more on this

 

 

Published: Sep 29, 2014

Akebia Announces Dosing of First Patient in Phase 2 Study of AKB-6548 in Patients with Anemia Related to Chronic Kidney Disease Undergoing Dialysis
Read more on this

 

 

Published: May 22, 2014

Antidote for rapid reversal of Pradaxa® (dabigatran etexilate) progresses into next stage of clinical investigation with study in patients
Read more on this

 

 

Published: Feb 10, 2014

Transfusion Medicine Becomes NATA's Official Journal
Read more on this

 

 

Published: Dec 11, 2013

ASH Choosing Wisely® Campaign Recommends Avoiding Liberal RBC Transfusion
Read more on this

 

 

Published: Oct 1, 2013

ANZSBT/NATA Perioperative Patient Blood Management Symposium
Read more on this

 

 

Published: Jul 25, 2013

Ferric Carboxymaltose Receives US FDA Approval for the Treatment of Iron Deficiency Anemia
Read more on this

 

 

Published: Jun 27, 2013

European Medicines Agency’s Pharmacovigilance Risk Assessment Committee Recommends Suspending Marketing Authorizations for Infusion Solutions Containing Hydroxyethyl Starch
Read more on this

 

Pages